| Objective: To analyze the association of polymorphisms for BsmIã€ApaIã€TaqI at the vitamin d receptor locus and serum levels of25(OH)D with the prognosis of HBV related acute on chronic liver failure.Methods: We performed a caseâ€control study,a total of153HBV related acute on chronic liver failure patients and HBV carriers were included with a followed up of3months. The polymorphisms for BsmIã€ApaIã€TaqI at the vitamin d receptor locus and serum levels of25(OH)D were analysed, and the cases survival rate were evaluated.Result: Of the153HBV related acute on chronic liver failure patients, the sur-vival rate is74.51%. The b allele and genotype bb of BsmI SNPs were morefrequently in HBV related acute on chronic liver failure patients (p<0.001and p<0.05,respectively).Either in survival group or in death group that b allele is more frequent than B allele(P=0.016,OR=0.467).Genotype bb was more frequent in death group than genotype BB and Bb(74.14%VS12.07%VS13.79%),and also genotype bb was more frequent in death group than in survival(74.14%VS38.60%,P<0.001,OR=4.614).HBV related acute on chronic liver failure patients had more lower25(OH)D concentration than HBV carrr-iers(10.40±2.92VS19.02±5.69ng/ml,P<0.001), lower25(OH)D concentration inversely correlate with MELD scores(rr=â€0.558), Concentrations of25(OH)D in death was lower than in survivals(8.18±2.23ng/ml VS11.29±2.70ng/ml,P<0.001).Basing on Kaplanâ€Meier analyses, serum25(OH)D concentration were associated with poor prognosis.Conclusion: Our results suggest that polymorphisms in vitamin d receptor are associated with prognosis of HBV related acute on chronic liver failure patients, and lower concentration of25(OH)D may suggest a poor prognosis, these findings could be helpful in identifying individuals at risk for bad outcomes and prompt physicians to offer more active treatments. |